PlanningRegister.ie
Cork County Council · 23/5763

Eli Lilly Pharmaceutical Complex Ballythomas East & Ballythomas West Dunderrow Kinsale, Co. Cork

Approved in Dec 2023. No sign of building yet.

Start notices are matched from the national building control register; a start on site can be missed.

  1. 30 Aug 2023Received
  2. 24 Oct 2023Conditional
  3. 1 Dec 2023Final approval
  4. 1 Dec 2028Approval runs out

An email when the builder tells the council work is starting.

Planning details

Status
Approved
Decision
Conditional · 24 Oct 2023
Reference
23/5763
Received
30 Aug 2023
Site
2,330 m²

What’s proposed

Permission for the construction of a pedestrian footbridge across an existing stream within the Eli Lily pharmaceutical facility, and associated works. The bridge will have a length of approx. 17.9m (13.1 span plus landing areas of 2.4m at either end) and a two-way 2.4m wide walkway and will be located on a site area of approx. 0.23ha.

Show all

The application site falls within the Eli Lilly industrial complex, which operates under an Industrial Emissions (IE) licence (P0009-04) under part IV of the Environmental Protection Agency Act 1992 (as amended by the protection of the Environmental Act, 2003) and is also an establishment to which the Chemicals Act (Control of Major Accident Hazards involving Dangerous Substances) Regulations 2015 (S.I. 209 of 2015) applies

6 other applications within 500 m in the last year

Open the report

Nearby 6 · 500 m · 12 months

Distance
Time

Explore this area on the map →

Homes nearby

Protections nearby 250 m

  • Recorded monument · 2
    Fulacht fia; R108281
Where this comes from

National planning feed (NPAD), fetched 18 Sept 2026, 15:44.

Source: National Planning Application Database · fetched 18 Sept 2026, 15:44
SourceLicenceFetchedLink
National Planning Application DatabaseCC BY 4.018 Sept 2026, 15:44open
Summary

23/5763 is a planning application to Cork County Council for permission for the construction of a pedestrian footbridge across an existing stream, received on 30 Aug 2023; permission was granted with conditions on 24 Oct 2023.